Business Overview - Guardian Pharmacy Services focuses on the Assisted Living Facilities (ALF) market, which is estimated to be around $7 billion[14] - The company has a 13% market share nationwide in the ALF & Memory Care market[22, 23] - Guardian serves approximately 140,000+ ALF residents and 204,000+ total residents[22] - The company dispenses approximately 28 million prescriptions annually[22] Financial Performance - The company's revenue for 2025 is projected to be $1.44 billion[60, 84] - Adjusted EBITDA for 2025 is projected to be $104-$106 million[81] - The company anticipates an Adjusted EBITDA margin of over 8% in 2026[81] - The company's cash conversion rate is approximately 60% year-to-date as of September 30, 2025[69, 70] Growth Strategy - The company is expanding into adjacent and new underserved markets through greenfield startups[37] - The company is targeting acquisitions with revenues between $10 million and $30 million, serving approximately 2,000 to 3,500 residents[42] - The company is implementing initiatives to mitigate the impact of the Inflation Reduction Act (IRA)[76]

Market Position and Growth - Guardian Pharmacy Services is a market leader in the Assisted Living Facility (ALF) market with a 13% market share[12] - The company serves over 189,000 residents[12] - The company has 32 pharmacies with > 40% Market Share[16] - The company has 12 pharmacies as Market Share Leader[16] - The company has 11 states with > 25% Market Share[15] - The company's revenue has grown at a CAGR of 15.8% from 2012 to 2024[19] Financial Performance - Adjusted EBITDA in 2024 was $90.834 million[60] - The company's Insurance Optimizer program resulted in ~$41 million in savings, or ~$514 per resident, for ~79,000 residents with claims[52] Acquisition Strategy - The company targets acquisitions with ~$10 - $30 million in revenue and ~2,000 - 3,500 residents[23] - Acquired pharmacies demonstrate strong revenue and resident growth after integration with Guardian[30]